or Try an Advanced Search...

    Technical Analysis for VOR - Vor Biopharma Inc.

    Grade Last Price % Change Price Change
    D 0.77 -3.11% -0.02
    VOR closed up 3.87 percent on Wednesday, November 20, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VOR trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish -3.11%
    NR7 Range Contraction -3.11%
    Stochastic Reached Oversold Weakness -3.11%
    Wide Bands Range Expansion -3.11%
    Oversold Stochastic Weakness -3.11%
    MACD Bearish Signal Line Cross Bearish 0.64%
    New Downtrend Bearish 0.64%
    Wide Bands Range Expansion 0.64%
    Down 3 Days in a Row Weakness 0.64%
    Down 4 Days in a Row Weakness 0.64%
    Older End-of-Day Signals for VOR ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    60 Minute Opening Range Breakdown about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VOR Chart by TradingView
    Basic chart:

    Profile

    Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis Lintuzumab

    Is VOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 Vor Biopharma GAAP EPS of -$0.40
    Nov 7 Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
    Sep 30 Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
    Sep 5 Vor Bio stock rallies post-market on trem-cel study data
    Sep 5 New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
    Sep 5 Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely
    Aug 9 Vor Biopharma GAAP EPS of -$0.41
    Aug 8 Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
    See more VOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.1399
    52 Week Low 0.63
    Average Volume 553,258
    200-Day Moving Average 1.32
    50-Day Moving Average 0.79
    20-Day Moving Average 0.83
    10-Day Moving Average 0.89
    Average True Range 0.08
    RSI (14) 47.37
    ADX 25.12
    +DI 23.92
    -DI 25.66
    Chandelier Exit (Long, 3 ATRs) 0.83
    Chandelier Exit (Short, 3 ATRs) 0.90
    Upper Bollinger Bands 1.01
    Lower Bollinger Band 0.65
    Percent B (%b) 0.4
    BandWidth 42.97
    MACD Line 0.02
    MACD Signal Line 0.03
    MACD Histogram -0.0114
    Fundamentals Value
    Market Cap 53.89 Million
    Num Shares 67.8 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.42
    Price-to-Sales 0.00
    Price-to-Book 0.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.88
    Resistance 3 (R3) 0.88 0.84 0.87
    Resistance 2 (R2) 0.84 0.82 0.85 0.86
    Resistance 1 (R1) 0.82 0.81 0.83 0.82 0.86
    Pivot Point 0.79 0.79 0.79 0.79 0.79
    Support 1 (S1) 0.76 0.77 0.77 0.77 0.73
    Support 2 (S2) 0.73 0.75 0.73 0.73
    Support 3 (S3) 0.71 0.73 0.72
    Support 4 (S4) 0.71